Kidney function and risk factors for left ventricular hypertrophy in untreated uncomplicated essential hypertension

Francesco Perticone1, Raffaele Maio, Carmen Ruberto

  • 1Department of Experimental and Clinical Medicine, G. Salvatore, University Magna Graecia of Catanzaro, Reggio Calabria, Italy.

Insights

Decreased kidney function is linked to left ventricular hypertrophy in hypertensive patients, partly due to factors like insulin resistance. This highlights the cardiovascular impact of kidney health.

Area of Science:

  • Cardiology
  • Nephrology
  • Metabolic Syndrome

Background:

  • Left ventricular (LV) hypertrophy and reduced kidney function are significant cardiovascular risk factors in hypertensive individuals.
  • Hypertension management requires understanding multifactorial risks for cardiac complications.

Purpose of the Study:

  • To investigate the relationship between kidney function markers (creatinine, creatinine clearance, eGFR) and left ventricular mass (LVM) in patients with essential hypertension.
  • To determine if kidney function independently predicts LV mass and to explore mediating factors.

Main Methods:

  • Cross-sectional study of 400 untreated hypertensive patients.
  • Measured LV mass index (LVMI), estimated glomerular filtration rate (eGFR) using the MDRD equation, and serum creatinine.
  • Assessed Framingham risk factors, endothelial function (ACh-stimulated FBF), insulin sensitivity (HOMA-R), C-reactive protein (CRP), and uric acid.

Main Results:

  • Both eGFR and creatinine levels showed significant associations with LVMI (P < 0.001).
  • eGFR remained independently associated with LVMI after adjusting for Framingham risk factors.
  • This association weakened after accounting for specific factors like insulin resistance (HOMA-R), endothelial function, CRP, and uric acid.
  • A significant interaction was found between eGFR and insulin resistance in explaining LVMI variability (P = 0.007).

Conclusions:

  • Decreased kidney function independently contributes to left ventricular hypertrophy in hypertensive patients.
  • The link between kidney function and LVMI is partly mediated by insulin resistance, endothelial dysfunction, CRP, and uric acid levels.
  • Kidney function and insulin resistance interact synergistically in the development of left ventricular hypertrophy.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...